1. Home
  2. APLS vs FHB Comparison

APLS vs FHB Comparison

Compare APLS & FHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • FHB
  • Stock Information
  • Founded
  • APLS 2009
  • FHB 1858
  • Country
  • APLS United States
  • FHB United States
  • Employees
  • APLS N/A
  • FHB N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • FHB Major Banks
  • Sector
  • APLS Health Care
  • FHB Finance
  • Exchange
  • APLS Nasdaq
  • FHB Nasdaq
  • Market Cap
  • APLS 3.5B
  • FHB 3.2B
  • IPO Year
  • APLS 2017
  • FHB 2016
  • Fundamental
  • Price
  • APLS $25.17
  • FHB $25.71
  • Analyst Decision
  • APLS Buy
  • FHB Sell
  • Analyst Count
  • APLS 20
  • FHB 9
  • Target Price
  • APLS $34.11
  • FHB $26.72
  • AVG Volume (30 Days)
  • APLS 2.1M
  • FHB 977.5K
  • Earning Date
  • APLS 11-04-2025
  • FHB 10-24-2025
  • Dividend Yield
  • APLS N/A
  • FHB 4.04%
  • EPS Growth
  • APLS N/A
  • FHB 11.02
  • EPS
  • APLS N/A
  • FHB 1.93
  • Revenue
  • APLS $754,649,000.00
  • FHB $805,018,000.00
  • Revenue This Year
  • APLS $20.59
  • FHB $10.45
  • Revenue Next Year
  • APLS N/A
  • FHB $2.57
  • P/E Ratio
  • APLS N/A
  • FHB $13.33
  • Revenue Growth
  • APLS 20.02
  • FHB 0.27
  • 52 Week Low
  • APLS $16.10
  • FHB $20.32
  • 52 Week High
  • APLS $39.51
  • FHB $28.80
  • Technical
  • Relative Strength Index (RSI)
  • APLS 44.82
  • FHB 56.88
  • Support Level
  • APLS $27.26
  • FHB $25.37
  • Resistance Level
  • APLS $28.97
  • FHB $25.96
  • Average True Range (ATR)
  • APLS 0.99
  • FHB 0.44
  • MACD
  • APLS -0.58
  • FHB -0.01
  • Stochastic Oscillator
  • APLS 11.00
  • FHB 52.06

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

Share on Social Networks: